from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1076/lipU

LFCtreatmentdescriptionclass of inhibitor

-1.312

Amikacinug/mL Amikacintranslation

-0.553

Cap5-10ug/mL Capreomycintranslation

-0.124

Rox10-50 ug/mL Roxithromycintranslation

-1.110

SM2-5 ug/mL Streptomycintranslation

-0.682

Tet5-10 ug/mL Tetracyclinetranslation

-1.528

Rif0.2-5ug/mL Rifampicintranscription

-0.866

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.038

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.603

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.032

CPZ10-50 ug/mL Chlorpromazinerespiration

0.082

Clofazimine10-13 ug/mL Clofaziminerespiration

0.167

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.060

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.351

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.823

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.059

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.501

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.123

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.419

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.065

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.897

KCN5-20 ug/mL Potassium cyaniderespiration

0.746

NaN30.2-2 mM Sodium aziderespiration

0.043

Nigericin50 uM Nigericinrespiration

0.042

TRC10-150 ug/mL Triclosanrespiration

0.880

TRZ10-25 ug/mL Thioridazinerespiration

-0.279

Valinomycin0.5-10 uM Valinomycinrespiration

0.402

ZnSO42 mM ZnSO4respiration

-1.651

menadione6-10 ug/mL Menadionerespiration

-0.579

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.139

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.164

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.206

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.531

NRP_1Non-replicating persistence stage 1dosRassociated

0.066

Amp0.2mg/mL AmpicillincellWall

-0.039

Cephalexin20-100 ug/mL CephalexincellWall

-0.052

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.534

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.101

EMB10-20 ug/mL EthambutolcellWall

1.028

Eta12-40 ug/mL EthionamidecellWall

0.720

INH0.2-0.4 ug/mL IsoniazidcellWall

0.221

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.963

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.216

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.116

BZA0.12 mg/mL BenzamidearomaticAmides

-0.057

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.280

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.513

H2O24 mM hydrogen peroxideDNAdamaging

-0.425

Levo10 ug/mL LevofloxacinDNAdamaging

-0.630

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.038

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.701

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.135

UVUV-irradiationDNAdamaging

-0.111

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.451

Antimycin12.5-50 ug/mL Antimycin A?

0.518

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.439

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.199

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.760

PA8240.2-2 ug/mL PA-824?

0.831

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.090

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.464

Verapamil50 uM Verapamil?

0.463

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.173

methoxatin10-20 ug/mL Methoxatin?